These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6473495)

  • 1. Effect of composition on the neutralizing properties of antacid preparations.
    Pawlaczyk J; Lutka A; Kokot Z
    Pharmazie; 1984 May; 39(5):334-6. PubMed ID: 6473495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of neutralizing properties of antacid preparations. Part 7. 27Al NMR studies of aluminum species formed during acid dissolution of some antacid preparations.
    Kokot Z
    Pharmazie; 1989 Dec; 44(12):828-30. PubMed ID: 2635320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of almagate and pharmaceutical formulations prepared from it.
    Fábregas JL; Beneyto JE
    Arzneimittelforschung; 1984; 34(10A):1354-7. PubMed ID: 6548919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
    Hem SL; White JL; Buehler JD; Luber JR; Grim WM; Lipka EA
    Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new antacid, almagate.
    Beneyto JE; Fábregas JL; Moragues J; Spickett RG
    Arzneimittelforschung; 1984; 34(10A):1350-4. PubMed ID: 6439224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of neutralizing properties of antacid preparations. Part 4: Application of Weibull distribution function to neutralization of dihydroxyaluminum sodium carbonate.
    Kokot Z
    Pharmazie; 1988 Jul; 43(7):481-3. PubMed ID: 3222278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of neutralizing properties of antacid preparations. Part 5: Dissolution kinetics of dihydroxyaluminum aminoacetate.
    Kokot Z
    Pharmazie; 1989 Apr; 44(4):274-5. PubMed ID: 2772001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a new crystalline synthetic gastric antacid, almagate.
    Moragues J; Beneyto JE; Fábregas JL; Spickett RG
    Arzneimittelforschung; 1984; 34(10A):1346-9. PubMed ID: 6548918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of neutralizing properties of antacid preparations. Part 3: Constant pH neutralization of hydrochloric acid by hydrotalcite.
    Kokot Z
    Pharmazie; 1988 Apr; 43(4):249-51. PubMed ID: 3413211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the in vitro interactions of cimetidine with commercial antacid preparations and chemically pure components.
    Allgayer H; Paumgartner G
    Arzneimittelforschung; 1984; 34(8):870-1. PubMed ID: 6541923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of antacid value of magnesium-aluminium trisilicate dihydrate tablets.
    Jovanović M; Todorović G; Djurić Z; Bulajić V
    Pharmazie; 1985 Nov; 40(11):807. PubMed ID: 4095135
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of proteolytic enzymes and polypeptides on the antacid activity of almagate and other antacids.
    Beneyto JE; Fábregas JL
    Arzneimittelforschung; 1984; 34(10A):1357-60. PubMed ID: 6391496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing capacity and cost effectiveness of antacids.
    Drake D; Hollander D
    Ann Intern Med; 1981 Feb; 94(2):215-7. PubMed ID: 6781389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotelemetric comparison of two antacids using the Heidelberg capsule.
    Gómez Puch LM; Ríos Solans G; Muñoz y Fernandez JR
    Arzneimittelforschung; 1984; 34(10A):1378-80. PubMed ID: 6548925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of antacid compounds containing both aluminum and magnesium. II. Codried powders.
    Peterson CL; Perry DL; Masood H; White JL; Hem SL; Fritsch C; Haeusler F
    Pharm Res; 1993 Jul; 10(7):1005-7. PubMed ID: 8378241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir.
    Krishna R; East L; Larson P; Valiathan C; Butterfield K; Teng Y; Hernandez-Illas M
    J Pharm Pharmacol; 2016 Nov; 68(11):1359-1365. PubMed ID: 27671833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-neutralizing capacity and sodium content of antacid products from Belgium.
    Gombatz VW
    Clin Ther; 1984; 6(2):151-4. PubMed ID: 6705010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro acid reactivity of three commercial antacid tablets.
    Spivey RJ; Goodhart FW
    Am J Hosp Pharm; 1979 May; 36(5):660-3. PubMed ID: 36756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug interactions during storage of mixtures of the antacid group. III. Effect of relative humidity on structural changes in mixtures aluminum hydroxide gel and magnesium hydroxide in the solid phase].
    Pawlaczyk J; Lutka A
    Acta Pol Pharm; 1989; 46(2):170-3. PubMed ID: 2631571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS; Sun P; Yu HY
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.